BCL2 and cancer: It has been very well established that the B-cell lymphoma 2 (BCL-2) family, including BCL-2, BCL-xL and myeloid cell leukemia 1, are involved in cell death control and apoptosis pathways as well as resistance to traditional chemotherapy agents in many cancers [29].